Identification of microRNAs involved in acute rejection and spontaneous tolerance in murine hepatic allografts

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Morita, Miwa ^a,b   Chen, Jiajie ^a,c   Fujino, Masayuki ^a,d   Kitazawa, Yusuke ^a   Sugioka, Atsushi ^b   Zhong, Liang ^c   Li, Xiao Kang ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUDAN UNIVERSITY   (China)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MICRORNA;

ALLOGRAFT; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE;

ALLOGRAFTS; ANIMALS; GENE EXPRESSION REGULATION; GRAFT REJECTION; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICRORNAS;

EID: 84935058156     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06649     Document Type: Article

References (64)

1. Orlando, G., Soker, S. & Wood, K. Operational tolerance after liver transplantation. J Hepatol 50, 1247-1257 (2009).
2. Kawasaki, M. et al. Gene expression profile analysis of the peripheral blood mononuclear cells from tolerant living-donor liver transplant recipients. Int Surg 92, 276-286 (2007).
3. Calne, R. Y. et al. Induction of immunological tolerance by porcine liver allografts. Nature 223, 472-476 (1969).
4. Kamada, N., Brons, G. & Davies, H. S. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 29, 429-431 (1980).
5. Morita, M. et al. PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant 10, 40-46 (2010).
6. Morita, M. et al. Spontaneous tolerance involving natural killer T cells after hepatic grafting in mice. Transpl Immunol 18, 142-145 (2007).
7. Xie, L. et al. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance. Liver Transpl 18, 444-454 (2012).
8. Pasquinelli, A. E. et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86-89 (2000).
9. Pritchard, C. C., Cheng, H. H. &Tewari, M. MicroRNA profiling: approaches and considerations. Nat Rev Genet 13, 358-369 (2012).
10. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998).
11. Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L. & Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res 14, 1902-1910 (2004).
12. Baltimore, D., and Boldin, M. P., O'Connell, R. M., Rao, D. S. & Taganov, K. D. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9, 839-845 (2008).
13. Sonkoly, E., Stahle, M. & Pivarcsi, A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18, 131-140 (2008).
14. Li, W., Zheng, X.X., Kuhr, C. S. & Perkins, J.D. CTLA4 engagementis required for induction of murine liver transplant spontaneous tolerance. Am J Transplant 5, 978-986 (2005).
15. Shi, Y. et al. Gene silencing of 4-1BB by RNA interference inhibits acute rejection in rats with liver transplantation. Biomed Res Int 2013, 192738 (2013).
16. Cai, P. et al. MicroRNA-Gene Expression Network in Murine Liver during Schistosoma japonicum Infection. PLoS One 8, e67037 (2013).
17. Harraz, M. M., and Eacker, S. M., Wang, X., Dawson, T. M. & Dawson, V. L. MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proc Natl Acad Sci U S A 109, 18962-18967 (2012).
18. Merkerova, M., Belickova, M. & Bruchova, H. Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol 81, 304-310 (2008).
19. Haneklaus, M., Gerlic, M., O'Neill, L. A. & Masters, S. L. miR-223: infection, inflammation and cancer. J Intern Med 274, 215-226 (2013).
20. O'Connell, R. M., Zhao, J. L. & Rao, D. S. MicroRNA function in myeloid biology. Blood 118, 2960-2969 (2011).
21. Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125-1129 (2008).
22. Liu, Q. et al. miR-223 suppresses differentiation of tumor-induced CD11b(+) Gr1(+) myeloid-derived suppressor cells from bone marrow cells. Int J Cancer 129, 2662-2673 (2011).
23. Gabrilovich, D. I. & Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9, 162-174 (2009).
24. Anglicheau, D. et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A 106, 5330-5335 (2009).
25. Sui, W. et al. Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. Transpl Immunol 19, 81-85 (2008).
26. Hu, J. et al. Plasma MicroRNA, a Potential Biomarker for Acute Rejection After Liver Transplantation. Transplantation 95, 991-999 (2013).
27. Taganov, K. D., Boldin, M.P., Chang, K.J.& Baltimore, D.NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103, 12481-12486 (2006).
28. Monticelli, S. et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol 6, R71 (2005).
29. Jiang, P. et al. MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages. Exp Cell Res 318, 1175-1184 (2012).
30. Kauppinen, A., Suuronen, T., Ojala, J., Kaarniranta, K. & Salminen, A. Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 25, 1939-1948 (2013).
31. Lee, J. et al. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem 285, 12604-12611 (2010).
32. Hsieh, C. H. et al. Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharides. J Biomed Sci 19, 69 (2012).
33. An, F. et al. miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure. Apoptosis 17, 702-716 (2012).
34. Zhang, Y. et al. Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease. Diabetes Res Clin Pract 99, 327-334 (2013).
35. Ridolfi, E. et al. Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis. Int J Mol Sci 14, 4375-4384 (2013).
36. Paraskevi, A. et al. Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis 6, 900-904 (2012).
37. Xu, Y., Zhou, B., Wu, D., Yin, Z. & Luo, D. Baicalin modulates microRNA expression in UVB irradiated mouse skin. J Biomed Res 26, 125-134 (2012).
38. Cheng, Y. et al. Downregulation of miR-27a and miR-532-5p and upregulation of miR-146a and miR-155 in LPS-induced RAW264.7 macrophage cells. Inflammation 35, 1308-1313 (2012).
39. Thulasingam, S. et al. miR-27b, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells. Mol Cell Biochem 352, 181-188 (2011).
40. Lu, M. H. et al. microRNA-27b suppresses mouse MSC migration to the liver by targeting SDF-1alphain vitro. Biochem Biophys Res Commun 421, 389-395 (2012).
41. Lewis, B. P., and Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. & Burge, C. B. Prediction of mammalian microRNA targets. Cell 115, 787-798 (2003).
42. Ouwehand, K. et al. CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur J Immunol 38, 3050-3059 (2008).
43. Rasmussen, K. D. et al. The miR-144/451 locus is required for erythroid homeostasis. J Exp Med 207, 1351-1358 (2010).
44. Zhang, X. et al. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol 49, 841-850 (2010).
45. Alisi, A. et al. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest 91, 283-293 (2011).
46. Li, C. et al. Analysis of intragraft microRNA expression in a mouse-to-rat cardiac xenotransplantation model. Microsurgery 34, 44-50 (2014).
47. Zhu, Q. Y., Liu, Q., Chen, J. X., Lan, K. & Ge, B. X. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol 185, 7435-7442 (2010).
48. Yoshioka, W., Higashiyama, W. & Tohyama, C. Involvement of microRNAs in dioxin-induced liver damage in the mouse. Toxicol Sci 122, 457-465 (2011).
49. Dai, R. et al. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 5, e14302 (2010).
50. Yu, D. et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450, 299-303 (2007).
51. Hao, Y. et al. Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila) 4, 1073-1083 (2011).
52. Zhang, J., Han, C., Zhu, H., Song, K. & Wu, T. miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF). Am J Pathol 182, 1629-1639 (2013).
53. Tanaka, T., Haneda, S., Imakawa, K., Sakai, S. & Nagaoka, K. A microRNA, miR-101a, controls mammary gland development by regulating cyclooxygenase-2 expression. Differentiation 77, 181-187 (2009).
54. Schaefer, J. S., Montufar-Solis, D., Vigneswaran, N. & Klein, J. R. Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-102/2 mice precedes expression in the colon. J Immunol 187, 5834-5841 (2011).
55. Warg, L. A. et al. The role of the E2F1 transcription factor in the innate immune response to systemic LPS. Am J Physiol Lung Cell Mol Physiol 303, L391-400 (2012).
56. De Martino, I. et al. Regulation of microRNA expression by HMGA1 proteins. Oncogene 28, 1432-1442 (2009).
57. Farid, W.R. et al. Hepatocyte-derived microRNAs asserum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 18, 290-297 (2012).
58. Li, C., Ebert, P. J. & Li, Q. J. T cell receptor (TCR) and transforming growth factor beta (TGF-beta) signaling converge on DNA (cytosine-5)-methyltransferase to control forkhead box protein 3 (foxp3) locus methylation and inducible regulatory T cell differentiation. J Biol Chem 288, 19127-19139 (2013).
59. Manaster, I. et al. MiRNA-mediated control of HLA-G expression and function. PLoS One 7, e33395 (2012).
60. Ason, B. et al. Differences in vertebrate microRNA expression. Proc Natl Acad Sci U S A 103, 14385-14389 (2006).
61. Lagos-Quintana, M. et al. Identification of tissue-specific microRNAs from mouse. Curr Biol 12, 735-739 (2002).
62. Wang, K. et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106, 4402-4407 (2009).
63. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105, 10513-10518 (2008).
64. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25, 658-663 (1997).